Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Resmed Inc (RMD.AX)

Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Resmed Inc 9001 Spectrum Center Boulevard San Diego CA 92123 USA

https://www.resmed.com P: 858-836-5000

Description:

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Key Statistics

Overview:

Market Capitalization, $K 52,933,875
Shares Outstanding, K 1,467,957
Annual Sales, $ 4,685 M
Annual Net Income, $ 1,021 M
Last Quarter Sales, $ 1,225 M
Last Quarter Net Income, $ 311,355 K
% of Institutional Shareholders 12.34%

Growth:

1-Year Return 57.17%
3-Year Return 0.91%
5-Year Return 69.96%
5-Year Revenue Growth 12.44%
5-Year Earnings Growth 19.84%

Per-Share Information:

Most Recent Earnings 0.21 on 10/25/24
Next Earnings Date N/A
Earnings Per Share ttm 0.75
EPS Growth vs. Prev Qtr 6.57%
EPS Growth vs. Prev Year 0.14%
Annual Dividend Rate, $ 0.20
Annual Dividend Yield 0.88%
Most Recent Dividend 0.053 on 11/06/24
Next Ex-Dividends Date 11/06/24
Dividend Payable Date 12/12/24
Dividend Payout Ratio 26.13%
Most Recent Split 2-1 on 08/12/10

RMD.AX Ratios

Ratio
Price/Earnings ttm 31.75
Price/Earnings forward 26.18
Return-on-Equity % 23.56%
Return-on-Assets % 15.94%
Profit Margin % 21.79%
Debt/Equity 0.17
Price/Sales 7.18
Price/Book 6.76
Book Value/Share 5.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar